干细胞移植治疗2型糖尿病急性心肌梗死的研究进展  

Research progress on stem cell transplantation for the treatment of acute myocardial Infarction in Type 2 diabetes

作　　者：雷川云 柯亭羽[1] 徐勉[1] 

机构地区：[1]昆明医科大学第二附属医院老年内分泌科,云南昆明650101

出　　处：《中国医药科学》2013年第19期36-38,共3页China Medicine And Pharmacy

基　　金：国家自然科学基金资助项目(31260223);国家自然科学基金项目(81260229);云南省科技厅-昆明医科大学联合专项基金(2012FB044)

摘　　要：与2型糖尿病联系最紧密的莫过于心脏及血管系统,而心脏的干细胞移植治疗给心血管疾病带来了曙光,经诸多生物科学家研究显示,此种方式可加强左心室的收缩期强度,减轻心室肌重构,减慢心衰的生物学进展,从而改善生活质量,延长生命。本研究就干细胞治疗2型糖尿病心肌梗死的研究进行了阐述及对新进展的展望。Cardiovascular diseases are most closely connected with Type 2 diabetes.Yet stem cells implantation may,according to many scientists, bring this kind of people a great hope,this method can contribute to heart muscle repair.In the recent period, a majority of experiments have studied the assumption that stem cells might better the capacity of recovery of LV function after acute myocardial infarction, reduce the structure of ventricular muscle remodeling,and slow down the process of heart failure,improving the quality of life and extending the life span.This article illustrates the researches of treatments of the myocardial infarction in type2 diabetes by stem cell transplanting, and look forward to the prospects for the new development.

关 键 词：心肌梗死 干细胞移植 2型糖尿病 新进展 

分 类 号：R587.1[医药卫生—内分泌]